DK1062952T3 - Brusende enteropræparater - Google Patents
Brusende enteropræparaterInfo
- Publication number
- DK1062952T3 DK1062952T3 DK99939145T DK99939145T DK1062952T3 DK 1062952 T3 DK1062952 T3 DK 1062952T3 DK 99939145 T DK99939145 T DK 99939145T DK 99939145 T DK99939145 T DK 99939145T DK 1062952 T3 DK1062952 T3 DK 1062952T3
- Authority
- DK
- Denmark
- Prior art keywords
- glycyrrhizin
- preparation
- present
- digestive tract
- effervescent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7648798 | 1998-03-11 | ||
PCT/JP1999/001157 WO1999045934A1 (fr) | 1998-03-11 | 1999-03-10 | Preparations entero-solubles effervescentes |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1062952T3 true DK1062952T3 (da) | 2003-11-24 |
Family
ID=13606583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99939145T DK1062952T3 (da) | 1998-03-11 | 1999-03-10 | Brusende enteropræparater |
Country Status (9)
Country | Link |
---|---|
US (1) | US6326360B1 (de) |
EP (1) | EP1062952B1 (de) |
JP (1) | JP4372347B2 (de) |
KR (1) | KR20010041696A (de) |
CN (1) | CN1160079C (de) |
AT (1) | ATE246506T1 (de) |
DE (1) | DE69910183T2 (de) |
DK (1) | DK1062952T3 (de) |
WO (1) | WO1999045934A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
US8119159B2 (en) * | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
US20070148228A1 (en) * | 1999-02-22 | 2007-06-28 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
EP1900364B1 (de) * | 2001-04-18 | 2013-09-25 | ProMetic BioSciences Inc. | Fettsäuren mit mittlerer Kettenlänge, Glyceride und Analoge als neutrophile Haltbarkeits- und Aktivierungsfaktoren |
WO2002092069A1 (en) * | 2001-05-11 | 2002-11-21 | Elan Corporation, Plc | Permeation enhancers |
JP2004529953A (ja) * | 2001-05-11 | 2004-09-30 | エラン コーポレーシヨン ピーエルシー | 浸透促進剤としてのイソステアリン酸塩 |
US20030068356A1 (en) * | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
JP3980851B2 (ja) * | 2001-08-30 | 2007-09-26 | 有限会社ゴトーコーポレーション | 固型製剤、その製造方法、及び食品 |
GB0217056D0 (en) * | 2002-07-23 | 2002-08-28 | Ass Octel | Use |
UA76641C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
UA76639C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
KR101120775B1 (ko) * | 2003-02-07 | 2012-04-18 | 프로메틱 바이오사이언시즈 인코포레이티드 | 적혈구생성의 자극제로서의 중쇄 지방산, 글리세리드 및유사체 |
CA2549642C (en) | 2003-12-31 | 2012-10-30 | Cima Labs Inc. | Effervescent oral opiate dosage forms and methods of administering opiates |
US7858121B2 (en) | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
WO2005065319A2 (en) * | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
CN101084016A (zh) * | 2004-04-15 | 2007-12-05 | 克艾思马有限公司 | 能够容易穿透生物学障碍的组合物 |
US20060067976A1 (en) | 2004-09-28 | 2006-03-30 | Atrium Medical Corporation | Formation of barrier layer |
EP1804717A4 (de) | 2004-09-28 | 2015-11-18 | Atrium Medical Corp | Arzneiabgabebeschichtung zur verwendung mit einem stent |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
CN100391466C (zh) * | 2006-02-17 | 2008-06-04 | 武汉大学 | 甘草酸铵盐在制备治疗炎症性肠病药物中的应用 |
RU2309732C1 (ru) | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
BRPI0710503A2 (pt) | 2006-04-07 | 2011-08-16 | Merrion Res Iii Ltd | uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral |
EA200802440A1 (ru) * | 2006-06-06 | 2009-06-30 | Олег Ильич ЭПШТЕЙН | Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе |
US20070292512A1 (en) * | 2006-06-09 | 2007-12-20 | Merrion Research Ii Limited | Solid Oral Dosage Form Containing an Enhancer |
WO2008057344A2 (en) | 2006-11-06 | 2008-05-15 | Atrium Medical Corporation | Coated surgical mesh |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
CN102046192B (zh) | 2008-05-07 | 2014-11-19 | 默里昂研究Ⅲ有限公司 | GnRH相关化合物的组合物及制备方法 |
CA2963659C (en) | 2008-09-17 | 2020-06-23 | Chiasma Inc. | Use of oral octreotride compositions |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US20130017245A1 (en) | 2010-03-23 | 2013-01-17 | Aska Pharmaceutical Co., Ltd. | Solid preparation |
US9089484B2 (en) | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
ES2440393R1 (es) | 2010-07-15 | 2014-10-10 | Oleg Iliich Epshtein | Un método para aumentar el efecto de una forma activada potenciada de un anticuerpo |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
MX2013000807A (es) | 2010-07-21 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para el tratamiento del trastorno de hiperactividad con deficit de atencion. |
RS57006B1 (sr) | 2010-10-07 | 2018-05-31 | California Inst Of Techn | Probiotičke terapije za autizam |
CN103476419A (zh) | 2011-01-07 | 2013-12-25 | 梅里翁第三研究有限公司 | 口服投药的含铁药物组合物 |
CN102499925B (zh) * | 2011-10-21 | 2015-11-11 | 上海中医药大学 | 一种中性粒细胞弹性蛋白酶抑制剂 |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
WO2014118997A1 (ja) * | 2013-01-30 | 2014-08-07 | 宏輝システムズ株式会社 | 新規多価アルコール基剤ソフトカプセル製剤 |
CN103330684A (zh) * | 2013-07-01 | 2013-10-02 | 杭州市西溪医院 | 甘草酸二铵脂质复合物泡腾颗粒的制备方法 |
JP2016029034A (ja) * | 2014-07-18 | 2016-03-03 | ナノメガ メディカル コーポレイションNanomega Medical Corporation | 医薬組成物 |
CN107205948B (zh) | 2015-01-29 | 2021-12-14 | 诺和诺德股份有限公司 | 包含glp-1激动剂和肠溶衣的片剂 |
AU2016215350B2 (en) | 2015-02-03 | 2021-11-25 | Amryt Endo, Inc. | Method of treating diseases |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5157813A (en) | 1974-11-14 | 1976-05-20 | Sankyo Co | Ll dooba mataha sonojudotaiseizaino seiho |
JPS6032714A (ja) * | 1983-08-01 | 1985-02-19 | Teijin Ltd | 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物 |
US4687662A (en) * | 1985-08-30 | 1987-08-18 | Warner-Lambert Company | Therapeutic effervescent composition |
JPH03255037A (ja) | 1990-03-02 | 1991-11-13 | Santen Pharmaceut Co Ltd | グリチルリチン製剤 |
JPH06192107A (ja) | 1992-12-25 | 1994-07-12 | Sanwa Kagaku Kenkyusho Co Ltd | グリチルリチン経口剤 |
JP3603327B2 (ja) | 1994-04-12 | 2004-12-22 | 大日本インキ化学工業株式会社 | 糖尿病治療剤 |
US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
US5498425A (en) * | 1995-03-17 | 1996-03-12 | Block Drug Company, Inc. | Phosphosoda buffered saline laxative |
-
1999
- 1999-03-10 DE DE69910183T patent/DE69910183T2/de not_active Expired - Fee Related
- 1999-03-10 AT AT99939145T patent/ATE246506T1/de not_active IP Right Cessation
- 1999-03-10 WO PCT/JP1999/001157 patent/WO1999045934A1/ja active IP Right Grant
- 1999-03-10 DK DK99939145T patent/DK1062952T3/da active
- 1999-03-10 EP EP99939145A patent/EP1062952B1/de not_active Expired - Lifetime
- 1999-03-10 KR KR1020007009915A patent/KR20010041696A/ko active IP Right Grant
- 1999-03-10 JP JP2000535349A patent/JP4372347B2/ja not_active Expired - Fee Related
- 1999-03-10 US US09/623,706 patent/US6326360B1/en not_active Expired - Fee Related
- 1999-03-10 CN CNB998038903A patent/CN1160079C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1292703A (zh) | 2001-04-25 |
EP1062952A4 (de) | 2002-06-12 |
EP1062952A1 (de) | 2000-12-27 |
US6326360B1 (en) | 2001-12-04 |
WO1999045934A1 (fr) | 1999-09-16 |
DE69910183T2 (de) | 2004-06-03 |
JP4372347B2 (ja) | 2009-11-25 |
CN1160079C (zh) | 2004-08-04 |
DE69910183D1 (de) | 2003-09-11 |
ATE246506T1 (de) | 2003-08-15 |
KR20010041696A (ko) | 2001-05-25 |
EP1062952B1 (de) | 2003-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1062952T3 (da) | Brusende enteropræparater | |
EE05450B1 (et) | 4-jodofenlaminobenshdroksaamhapete oksgeenitud estrid, nende kristallvormid ja farmatseutilised kompositsioonid ning kasutamine | |
MA26634A1 (fr) | Nouveaux derives de l'acide 3-aryl propionique et analogues | |
DE60018604D1 (de) | Säuglingsnährpräparat mit verbessertem proteingehalt | |
DE69534676D1 (de) | Orale Verabreichung von chemisch modifizierten Proteinen | |
DE69906066D1 (de) | Konzentrierte wässrige Bromlösungen und ihre Herstellung | |
EE200100113A (et) | Atsetüül-L-karnitiini ning alfa-lipohapet sisaldav oksüdeerumisvastane kompositsioon | |
NO176305C (no) | Fremgangsmåte for fremstilling av orale legemiddelformer av pimobendan | |
HUP0000450A3 (en) | The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases | |
NO984878D0 (no) | Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere | |
EE04490B1 (et) | Ühend, selle valmistamise meetod ning kasutamine meditsiinis | |
SE8505048D0 (sv) | Nutritionsemulsion med syretransporterande egenskaper | |
MY117606A (en) | Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids | |
BR0010189A (pt) | Suplemento de ácido fólico | |
NO992818D0 (no) | Anvendelse av pereddiksyre i fiskeoppdrett | |
PT912167E (pt) | Granulos de derivados de hexa-hidropirazina administraveis por via oral | |
DE69813846D1 (de) | Geschmacksmaskierung schlecht schmeckender formulierungen | |
DE69311306D1 (de) | Eisenhaltige zusammensetzung zur verhütung von anämie und verfahren zur herstellung der zusammensetzung | |
PT1312355E (pt) | Composicoes farmaceuticas nao-efervescentes soluveis em agua compreendendo drogas anti-inflamatorias nao-esteroides | |
GB9801142D0 (en) | Administration of beneficial substances to ruminant animals | |
GB2390543B (en) | Improvements in and relating to the administration of copper to an animal | |
AU637507B2 (en) | Herbicidal composition | |
DK0797997T3 (da) | Anvendelse af peptidiske bradykinin-antagonister til fremstilling af lægemidler | |
HK1049326B (zh) | 具有治療和/或營養活性的活性成分的不吸濕的鹽以及含有它們的可口服的組合物 | |
DE59010296D1 (de) | Polyethercarbonsäureester und ihre Herstellung |